BioGenes: Superior Services Since 1992
BioGenes is a full-service provider of customized immunoassays, analytical services and antibody development, with a strong commitment to quality and service.
The company was founded by its two managing directors, Alexander Knoll and Sergej Ovodov, in Berlin in 1992. Since then, BioGenes has been constantly growing its service and product range, as well as its strong team of specialists.
BioGenes in Numbers
- More than 30 years of expertise
- 10,000+ antibody and 400+ assay projects performed
- 5,000+ customers worldwide, including most of the Top 10 pharma companies
- 70 dedicated specialists in their respective fields
- 80%+ returning customers
Today, BioGenes is recognized as a reliable partner of the pharma and biotech industry across the world. Service is our special focus – from the first detailed offer to the in-depth consultancy with a project manager to the final customer satisfaction survey. Each project handled by BioGenes is treated with special care.
Other aspects that are valued by BioGenes' service partners are full flexibility and consistent quality. Whether they choose single services or want BioGenes to take over a whole project, we will always make sure to deliver the best possible results, as guaranteed by our rigorous quality policy and ISO-9001 certification.
Based on intensive market observations and incorporating the latest innovations, we are constantly expanding our service portfolio.
Highlights of the BioGenes Service and Product Range
A Dedicated Team
Our great team in Berlin is our biggest asset and we continue to grow and strive. From quality assurance to project management to antibody and HCP specialists, all team members work hand in hand to reach our goal: To make BioGenes one of the best and most reliable service providers worldwide.
Dr. Alexander Knoll
As founder and managing director of BioGenes, Dr. Alexander Knoll sets the company’s economic strategy and vision. He has held various positions in the life science industry and research, for example at the Humboldt-University, Berlin, FZB Biotechnik GmbH (enzymatic and microbial synthesis of chiral synthesis building blocks) and MolTech GmbH, and has performed in leadership, project management and marketing roles.
Dr. Sergej Ovodov
With his profound scientific knowledge and long experience in bio-organic chemistry Dr. Sergej Ovodov, co-founder of BioGenes, oversees the company´s scientific strategy and takes the lead across all scientific aspects of the company. He took over leading roles at the department for protein research at the Academy of Sciences, former Soviet Union and at FZB Biotechnik GmbH (cell-free biotechnology).
To ensure the long-term fulfillment of specific customer requirements for our products and services, our Quality Management System complies with each requirement and specification of the internationally accepted DIN EN ISO 9001 guidelines since 1999.
We follow a constant process of improvement and are audited annually by an independent certification company to maintain our certification status.
Our laboratory performance meets high quality requirements and is based on the following principles:
- Standardized work which follows SOPs
- Traceable documentation of manufacturing and analytical services according to data integrity principles
- Release testing of products by QC
- Risk-based approach in Quality Management Processes
- Experienced and well-trained personnel
- Using qualified equipment
- Conducting frequent internal and customer audits
- Deploying animals and materials from certified and qualified suppliers
BioGenes ensures that all services where work is carried out with and on animals meet specific animal welfare regulation, including but not limited to the following:
- German Guidelines: Tierschutzgesetz (TierSchG), engl. Animal Welfare Act of 18th May 2006 (BGBl. I S. 1206), last update from 20th December 2022
- German Guidelines: Tierschutz-Versuchstierverordnung (TierSchVersV), engl. Animal Welfare Ordinance on Experimental Animals of 01 August 2013 (BGBl. I S. 3125), last update from 11th August 2021
- European Union Guidelines: EU Directive 2010/63 of 09th November 2010 and the European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes of 18th March 1986
We at Biogenes believe that having strong partners with complementing expertise and knowledge is vital to be successful. Therefore, we have teamed up with the great companies below.
Want to become a BioGenes partner as well?
FyoniBio offers ISO 9001:2015 certified biopharmaceutical services at different stages of drug development. Their analytical/clinical lab is specialized in the development and validation of PK, biomarkers, immunogenicity assays and complex bioassays for analysis of (pre-) clinical samples, if necessary, under GCLP. website
trenzyme GmbH is a privately owned German Contract Research Organization (CRO) offering a wide range of highly customized services in cell line development, iPSC differentiation and recombinant protein production. website
Areas in which we cooperate with trenzyme: Protein Production
BIOSYNTAN GmbH was founded in 1997 as a scientific service company, focused on custom synthesis of peptides. Today, they are one of the leading specialists in the synthesis of linear and cyclic peptides with unusual residues and a multitude of modifications. website
Areas in which we cooperate with BIOSYNTAN: Peptide Synthesis
A current list of distributors for our HCP ELISA kits and components can be found here.
Why Work with Us
BioGenes is a top-level service provider of custom antibody and immunoassay development, and an expert in complex analytical services. For the last 30 years, customers from more than 40 countries have put their trust in our globally highly recognized services and products for the development, testing and production of biological therapeutics. Here is why:
If you need more information, a specific offer
or want to talk to an expert
Keep me updated